PostYou are now at: Home » Products » Chemicals » Chemical Stocks »

Methenolone Acetate

Click image to view original image
Brand: Western union, MoneyGram, Bank Transfer, Bitcoins
型号: Raw Chemicals, Pharmaceutical Intermediates.
规格: shanghai
Price: 1.00USD/g
Min.Order: 10 g
Supply 1 g
Delivery: Shipment within 1 days since the date of payment
Address: China
Valid until: 2020-09-10 [Expired]
Updated on: 2016-12-15 11:14
Hits: 178024
Company Detail
 
 
Details
Methenolone Acetate
Email: angel(at)health-gym(dot)com
Skype: live:angel_11616
Synonyms: primobolone;1(5a)-androsten-1beta-methyl-17beta-ol-3-one Acetate
CAS: 434-05-9 
EINECS: 207-097-0 
Molecular Formula: C22H32O3
Assay:97%-102%
specific rotation °+59~°+50 
melting point :144°C~136 °C
loss on drying :≤0.5 
residue on ignition ≤0.1 
Molecular Weight: 344.4877 
Character: White crystalline powder.
Usage: Primobolan is a good base compound in a stack and can produce results just slightly below that of nandrolone and is best used in a cutting stack. Because Primobolan doesn't aromatize, there is no use for Clomid or Nolvadex.
Methenolone Acetate Description: 
Primo is an almost pure anabolic with an extremely low androgenic component. The ratio of the anabolic to the androgenic effect is indeed very favorable but, since the overall anabolic effect is only moderately strong, Primo have only a limited effect in building up muscle mass and strength. With this steroid neither fast weight gains nor explosive strength gains occur. It is therefore mostly taken over a prolonged period since it gives only a slow but also a high-quality muscle gain which mostly remains after use of the compound is discontinued. Methenolone Acetate is an excellent oral steroid drug. Unlike most other orals, it is not 17-alkylated and does not have liver toxicity problems.
Email: angel(at)health-gym(dot)com
Skype: live:angel_11616
 
Total: 0 [Show All]  Related Reviews
 
More »Our Others Products

[ ProductsSearch ]  [ Add To Favourite ]  [ Tell Friends ]  [ Print Content ]  [ Violation Report ]  [ Close Window ]